Top Markets
#1 Pleasing Gold Pleasing Gold +1,499.28%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.75%
#4 Ontology Gas Ontology Gas +33.04%
#5 BOOK OF MEME BOOK OF MEME +29.14%
#6 ConstitutionDAO ConstitutionDAO +27.43%
#7 Collect on Fanable Collect on Fanable +24.55%
#8 Pump.fun Pump.fun +21.78%
#9 Unit Pump Unit Pump +21.78%
#10 Neiro Neiro +21.24%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
株式のランク #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
株価
$2.70
時価総額
$40.42M
変化（1日）
-1.28%
変化（1年）
-48.17%
国
US
取引 Serina Therapeutics, Inc. (SER)

カテゴリー

Healthcare
Serina Therapeutics, Inc.（SER）のP/S比率
2026 時点のP/S比率 TTM: 0
Serina Therapeutics, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
Serina Therapeutics, Inc. の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US